Potential therapeutic and economic value of risk-stratified treatment as initial treatment of multiple myeloma in Europe
{{output}}
Biomarkers associated with prognosis in multiple myeloma (MM) can be used to stratify patients into risk categories. An attractive alternative to uniform treatment (UT), risk-stratified treatment (RST) is proposed where high-risk patients receive bortezomib-ba... ...
